Patents by Inventor Melissa Junttila

Melissa Junttila has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS
    Publication number: 20220105180
    Abstract: The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer.
    Type: Application
    Filed: February 11, 2021
    Publication date: April 7, 2022
    Applicant: Genentech, Inc.
    Inventor: Melissa JUNTTILA
  • Methods of treating cancer using PD-1 axis binding antagonists and MEK inhibitors
    Patent number: 10946093
    Abstract: The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer.
    Type: Grant
    Filed: January 5, 2017
    Date of Patent: March 16, 2021
    Assignee: Genentech, Inc.
    Inventor: Melissa Junttila
  • METHODS OF TREATING CANCER USING PD-1 AXIS BINDING ANTAGONISTS AND MEK INHIBITORS
    Publication number: 20170112925
    Abstract: The present invention describes combination treatment comprising a PD-1 axis binding antagonist and a MEK inhibitor and methods for use thereof, including methods of treating conditions where enhanced immunogenicity is desired such as increasing tumor immunogenicity for the treatment of cancer.
    Type: Application
    Filed: January 5, 2017
    Publication date: April 27, 2017
    Applicant: Genentech, Inc.
    Inventor: Melissa JUNTTILA
  • Use of a growth-stimulating protein
    Patent number: 9062309
    Abstract: This invention relates to the inhibition of a newly discovered growth-stimulating protein in an individual. Further, the invention relates to a method for preventing or treating a cancer, or preventing or treating cancer growth, invasion or metastasis, or preventing or treating other hyperproliferative diseases in an individual, by down regulating the expression of said growth-stimulating protein or by inactivating said protein. Still further, the invention concerns a method for diagnosing cancer or other hyperproliferative diseases in an individual based on said growth-stimulating protein.
    Type: Grant
    Filed: March 22, 2013
    Date of Patent: June 23, 2015
    Assignee: TURUN YLIOPISTO
    Inventors: Jukka Westermarck, Pietri Puustinen, Melissa Junttila
  • Use of a growth-stimulating protein
    Patent number: 8410072
    Abstract: This invention relates to the inhibition of a newly discovered growth-stimulating protein in an individual. Further, the invention relates to a method for preventing or treating a cancer, or preventing or treating cancer growth, invasion or metastasis, or preventing or treating other hyperproliferative diseases in an individual, by down regulating the expression of said growth-stimulating protein or by inactivating said protein. Still further, the invention concerns a method for diagnosing cancer or other hyperproliferative diseases in an individual based on said growth-stimulating protein.
    Type: Grant
    Filed: September 27, 2011
    Date of Patent: April 2, 2013
    Assignee: Turun Yliopisto
    Inventors: Jukka Westermarck, Pietri Puustinen, Melissa Junttila
  • USE OF A GROWTH-STIMULATING PROTEIN
    Publication number: 20120077750
    Abstract: This invention relates to the inhibition of a newly discovered growth-stimulating protein in an individual. Further, the invention relates to a method for preventing or treating a cancer, or preventing or treating cancer growth, invasion or metastasis, or preventing or treating other hyperproliferative diseases in an individual, by down regulating the expression of said growth-stimulating protein or by inactivating said protein. Still further, the invention concerns a method for diagnosing cancer or other hyperproliferative diseases in an individual based on said growth-stimulating protein.
    Type: Application
    Filed: September 27, 2011
    Publication date: March 29, 2012
    Inventors: Jukka WESTERMARCK, Pietri PUUSTINEN, Melissa JUNTTILA
  • Use Of A Growth-Stimulating Protein
    Publication number: 20090232821
    Abstract: This invention relates to the inhibition of a newly discovered growth-stimulating protein in an individual. Further, the invention relates to a method for preventing or treating a cancer, or preventing or treating cancer growth, invasion or metastasis, or preventing or treating other hyperproliferative diseases in an individual, by down regulating the expression of said growth-stimulating protein or by inactivating said protein. Still further, the invention concerns a method for diagnosing cancer or other hyperproliferative diseases in an individual based on said growth-stimulating protein.
    Type: Application
    Filed: March 14, 2007
    Publication date: September 17, 2009
    Inventors: Jukka Westermarck, Pietri Puustinen, Melissa Junttila